Professor David Paterson

Featured projects	Duration
Culture-independent metagenomic diagnostics Genome Innovation Hub Collaborative Project (UQ infrastructure)	2021

Paterson, David L. and Bonomo, Robert A. (2019). Multidrug-resistant gram-negative pathogens: the urgent need for 'old' polymyxins. Polymyxin antibiotics: from laboratory bench to bedside. (pp. 9-13) edited by Jian Li, Roger L. Nation and Keith S. Kaye. Cham, Switzerland: Springer. doi: 10.1007/978-3-030-16373-0_2

Grayson, M. Lindsay, Cosgrove, Sara E., Crowe, Suzanne M., McCarthy, James S., Hope, William, Mills, John, Mouton, Johan W. and Paterson, David L. (2017). Principles of antimicrobial use. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 3-8) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110

Yilmaz, Mesut and Paterson, David L. (2017). Ceftizoxime, cefdinir, cefditoren, cefpodoxime, ceftibuten, cefsulodin, and cefpiramide. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 530-538) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110

Baba, Hisashi and Paterson, David L. (2017). Cefotiam, cefuzonam, cefamandole, cefonicid, and ceforanide. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 396-402) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110

Paterson, David L. (2017). Cefiderocol (S-649266). Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 658-659) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110

Paterson, David L. and Doi, Yohei (2017). Cefaclor, cefprozil, and loracarbef. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 376-382) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110

Hayashi, Yoshiro and Paterson, David L. (2017). Imipenem-cilastatin and imipenem-relebactam. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 663-696) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110

Paterson, David L. (2017). Cefadroxil, cephaloridine, cephacetrile, cephapirin, cephradine, and other rarely used first-generation cephalosporins. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 370-375) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110

Henderson, Andrew, Kim, Baek-Nam and Paterson, David L. (2017). Ceftobiprole. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 619-635) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110

Kim, Baek-Nam and Paterson, David L. (2017). Cefotaxime. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 426-463) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110

Kim, Baek-Nam, Peri, Anna Maria and Paterson, David L. (2017). Ceftriaxone. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 464-529) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110

Hayashi, Yoshiro and Paterson, David L. (2011). The epidemiology of pan/extreme drug resistance. Antibiotic policies: controlling hospital acquired infection. (pp. 27-38) edited by Ian M. Gould and Jos W.M. van der Meer. New York, United States: Springer. doi: 10.1007/978-1-4419-1734-8_3

Paterson, David L. (2011). Infections due to other members of the enterobacteriaceae, including management of multidrug-resistant strains. Goldman's Cecil medicine. (pp. 1874-1877) edited by Lee Goldman and Andrew I. Schafer. Philadelphia, PA, United States: Elsevier Saunders. doi: 10.1016/B978-1-4377-1604-7.00313-4

Paterson, David L., Sidjabat, Hanna E. and Doi, Yohei (2010). Global spread of multidrug-resistant gram-negative bacilli. Emerging infections 9. (pp. 213-222) edited by W. Michael Scheld, M. Lindsay Grayson and James M. Hughes. Washington, United States: ASM Press. doi: 10.1128/9781555816803.ch10

DePestel, D., Hayashi, Y. and Paterson, D. L. (2010). Doripenem. Kucers' The Use of Antibiotic. (pp. 514-525) edited by M. Lindsay Grayson, Alvis Kucers and Suzanne Crowe. London, Engalnd, U.K.: Hodder Education.

Hayashi, Y. and Paterson, D.L. (2010). Imipenem. Kucers' the use of antibiotics. (pp. 471-499) edited by M. Lindsay Grayson. London, UK: Hodder Education.

Paterson, D. L. and Doi, Y. (2010). Infections with Organisms Producing Extended-Spectrum beta-Lactamase. Antimicrobial resistance: beyond the breakpoint. (pp. 21-34) edited by J. T. Weber. Basel, Switzerland: Karger. doi: 10.1159/000298754

Silveira, Fernanda P. and Paterson, David L. (2007). Management of infections in living-donor transplant recipients. Living Donor Transplantation. (pp. 363-378) CRC Press.

Paterson, David L. and Boots, Robert J. (2000). Aspergillus. Fungal diseases of the lung. (pp. 123-162) edited by George A. Sarosi and Scott F. Davies.. Philadelphia: Lippincott Williams and Wilkins.

Peri, Anna Maria, O’Callaghan, Kevin, Rafiei, Nastaran, Bergh, Haakon, Tabah, Alexis, Chatfield, Mark D, Harris, Patrick NA and Paterson, David L (2024). Integrating omics techniques and culture-independent systems may improve the detection of persistent candidemia: data from an observational study. Annals of Clinical Microbiology and Antimicrobials, 23 (1) 75. doi: 10.1186/s12941-024-00736-w

Gibbs, Anna A.M., Laupland, Kevin B., Edwards, Felicity, Ling, Weiping, Channon-Wells, Samuel, Harley, David, Falster, Kathleen, Paterson, David L., Harris, Patrick N.A. and Irwin, Adam D. (2024). Trends in Enterobacterales Bloodstream Infections in Children. Pediatrics, 154 (4). doi: 10.1542/peds.2023-063532

Subedi, Shradha, Isler, Burcu, Ezure, Yukiko, Furuya-Kanamori, Luis, Eriksson, Lars, Paterson, David L and Harris, Patrick N. A. (2024). Performance characteristics of genus or species-specific Polymerase Chain Reaction (PCR) for the microbial diagnosis of joint infections: a systematic review and meta-analysis. Diagnostic Microbiology and Infectious Disease, 110 (1) 116422, 1-8. doi: 10.1016/j.diagmicrobio.2024.116422

Chew, Rusheng, Woods, Marion L and Paterson, David L (2024). Development and validation of supervised machine learning multivariable prediction models for the diagnosis of Pneumocystis jirovecii pneumonia using nasopharyngeal swab PCR in adults in a low-HIV prevalence setting. International Health. doi: 10.1093/inthealth/ihae052

Peri, Anna Maria, Chatfield, Mark D., Ling, Weiping, Furuya-Kanamori, Luis, Harris, Patrick N. A. and Paterson, David L. (2024). Rapid diagnostic tests and antimicrobial stewardship programs for the management of bloodstream infection: What is their relative contribution to improving clinical outcomes? A systematic review and network meta-analysis. Clinical Infectious Diseases, 79 (2), 502-515. doi: 10.1093/cid/ciae234

Khatri, Dipti, Falconer, Nazanin, de Camargo Catapan, Soraia, Coulter, Sonali, Gray, Leonard C., Paterson, David L. and Freeman, Christopher (2024). Exploring stakeholders’ perspectives on antibiogram use, development, and implementation in residential aged care settings. Research in Social and Administrative Pharmacy, 20 (8), 747-754. doi: 10.1016/j.sapharm.2024.04.011

Shiferaw, Wondimeneh, Martin, Beatris Mario, Dean, Judith A., Mills, Deborah, Lau, Colleen, Paterson, David, Koh, Kenneth, Eriksson, Lars and Furuya-Kanamori, Luis (2024). A systematic review and meta-analysis of sexually transmitted infections and blood-borne viruses in travellers. Journal of Travel Medicine, 31 (4) taae038. doi: 10.1093/jtm/taae038

Aslan, Abdullah Tarik and Paterson, David L. (2024). Epidemiology and clinical significance of carbapenemases in Australia: a narrative review. Internal Medicine Journal, 54 (4), 535-544. doi: 10.1111/imj.16374

Kain, Matthew J. W., Reece, Nicola L., Parry, Christopher M., Rajahram, Giri Shan, Paterson, David L. and Woolley, Stephen D. (2024). The rapid emergence of hypervirulent Klebsiella species and Burkholderia pseudomallei as major health threats in Southeast Asia: the urgent need for recognition as neglected tropical diseases. Tropical Medicine and Infectious Disease, 9 (4) 80. doi: 10.3390/tropicalmed9040080

Wise, Mark G., Karlowsky, James A., Mohamed, Naglaa, Hermsen, Elizabeth D., Kamat, Shweta, Townsend, Andy, Brink, Adrian, Soriano, Alex, Paterson, David L., Moore, Luke S.P. and Sahm, Daniel F. (2024). Global Trends in Carbapenem- and Difficult-to-Treat-Resistance Among World Health Organization Priority Bacterial Pathogens: ATLAS Surveillance Program 2018-2022. Journal of Global Antimicrobial Resistance, 37, 168-175. doi: 10.1016/j.jgar.2024.03.020

Horcajada, Juan P., Edwards, Felicity, Fonio, Silvia, Montero, Milagro, Harris, Patrick, Paterson, David L. and Laupland, Kevin B. (2024). Pseudomonas stutzeri bloodstream infection is a prevailing community-onset disease with important mortality rates: results from a retrospective observational study in Australia. Infectious Diseases, ahead-of-print (ahead-of-print), 1-10. doi: 10.1080/23744235.2024.2333979

Paterson, David L. (2024). Antibacterial agents active against Gram Negative Bacilli in phase I, II, or III clinical trials. Expert Opinion on Investigational Drugs, ahead-of-print (ahead-of-print), 1-17. doi: 10.1080/13543784.2024.2326028

Peri, Anna Maria, O’Callaghan, Kevin, Rafiei, Nastaran, Graves, Bianca, Sinclair, Holly, Brischetto, Anna, Lim, Karen, Parkes-Smith, Jill, Eustace, Matthew, Davidson, Natalie, Tabah, Alexis, Stewart, Adam, Chatfield, Mark D, Harris, Patrick NA and Paterson, David L (2024). Persistence of detectable pathogens by culture independent systems (T2 Magnetic Resonance) in patients with bloodstream infection: prognostic role and possible clinical implications. Clinical Infectious Diseases, 78 (2), 283-291. doi: 10.1093/cid/ciad663

Permana, Budi, Harris, Patrick N. A., Roberts, Leah W., Cuddihy, Thom, Paterson, David L., Beatson, Scott A. and Forde, Brian M. (2024). HAIviz: an interactive dashboard for visualising and integrating healthcare-associated genomic epidemiological data. Microbial Genomics, 10 (2) 001200. doi: 10.1099/mgen.0.001200

Chew, Rusheng, Tozer, Sarah, Ulett, Kimberly, Paterson, David L, Whiley, David, Sloots, Theo, Fielding, David, Zappala, Christopher, Bashirzadeh, Farzad, Hundloe, Justin, Bletchley, Cheryl and Woods, Marion L (2024). Comparison of nasopharyngeal swab vs. lower respiratory tract specimen PCR for the diagnosis of Pneumocystis jirovecii pneumonia. Open Forum Infectious Diseases, 11 (3) ofae071, ofae071. doi: 10.1093/ofid/ofae071

Peel, Trisha N., Paterson, David L. and de Steiger, Richard (2024). Trial of Vancomycin and Cefazolin as Surgical Prophylaxis. Reply. The New England journal of medicine, 390 (5), 481-482. doi: 10.1056/NEJMc2313673

Smolle, Maria A., Reinbacher, Patrick, Sadoghi, Patrick, Yusuf, Erlangga, Peel, Trisha N., Paterson, David L. and De Steiger, Richard (2024). Trial of Vancomycin and Cefazolin as Surgical Prophylaxis. New England Journal of Medicine, 390 (5), 480-482. doi: 10.1056/NEJMc2313673

Stewart, Adam G., Harris, Patrick N.A., Graham, Rikki M.A., Jennison, Amy V., Schlebusch, Sanmarie, Harris-Brown, Tiffany, Paterson, David L. and Forde, Brian M. (2024). Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trial. Pathology, 56, S36-S37. doi: 10.1016/j.pathol.2023.12.137

Wang, Minggui, Ge, Lizhao, Chen, Liang, Komarow, Lauren, Hanson, Blake, Reyes, Jinnethe, Cober, Eric, Alenazi, Thamer, Zong, Zhiyong, Xie, Qing, Liu, Zhengyin, Li, Lanjuan, Yu, Yunsong, Gao, Hainv, Kanj, Souha S., Figueroa, Jairo, Herc, Erica, Cordova, Ezequiel, Weston, Gregory, Ananth Tambyah, Paul, Garcia-Diaz, Julia, Kaye, Keith S., Dhar, Sorabh, Munita, Jose M., Salata, Robert A., Vilchez, Samuel, Stryjewski, Martin E., Villegas Botero, Maria Virginia, Iovleva, Alina ... Doi, Yohei (2024). Clinical outcomes and bacterial characteristics of carbapenem-resistant acinetobacter baumannii among patients from different global regions. Clinical Infectious Diseases, 78 (2), 248-258. doi: 10.1093/cid/ciad556

Aslan, Abdullah Tarik, Ezure, Yukiko, Harris, Patrick N. A. and Paterson, David L. (2024). Scoping review of risk-scoring tools for early prediction of bloodstream infections caused by carbapenem-resistant Enterobacterales: do we really have a reliable risk-scoring tool?. JAC-Antimicrobial Resistance, 6 (1) dlae032, 1-9. doi: 10.1093/jacamr/dlae032

Paterson, David L. and Sulaiman, Helmi bin (2024). “Real-World” Evidence, Target Trial Emulation, and Randomized Clinical Trials—Which Data Should Clinicians Rely on When Choosing Antibiotics?. JAMA Network Open, 7 (1), e2352250. doi: 10.1001/jamanetworkopen.2023.52250

Harris, Patrick N. A., Bauer, Michelle J., Lüftinger, Lukas, Beisken, Stephan, Forde, Brian M., Balch, Ross, Cotta, Menino, Schlapbach, Luregn, Raman, Sainath, Shekar, Kiran, Kruger, Peter, Lipman, Jeff, Bialasiewicz, Seweryn, Coin, Lachlan, Roberts, Jason A., Paterson, David L. and Irwin, Adam D. (2024). Rapid nanopore sequencing and predictive susceptibility testing of positive blood cultures from intensive care patients with sepsis. Microbiology spectrum, 12 (2) e0306523, e0306523. doi: 10.1128/spectrum.03065-23

Khatri, Dipti, Freeman, Christopher, Falconer, Nazanin, Catapan, Soraia De Camargo, Gray, Len and Paterson, David L. (2024). Clinical impact of antibiograms as an intervention to optimise antimicrobial prescribing and patient outcomes – a systematic review. American Journal of Infection Control, 52 (1), 107-122. doi: 10.1016/j.ajic.2023.08.013

Varon, Ben, Palacios-Baena, Zaira R., de Kraker, Marlieke E.A., Rodríguez-Baño, Jesús, Leibovici, Leonard, Paul, Mical, Bonten, Marc, Carmeli, Yehuda, Carrara, Elena, Chambers, Henry F., Davis, Joshua S., Daikos, George L., de Kraker, Marlieke, Durante-Mangoni, Emanuele, Huttner, Angela, Kalil, Andre C., Kaye, Keith, Lee, Todd C., Paterson, David, Gentil, Pilar Retamar, Baño, Jesus Rodríiguez, Scudeller, Luigia, Tacconelli, Evelina, Thwaites, Guy, Tong, Steven and Yahav, Dafna (2024). Universal Risk Factors for Mortality in Bloodstream Infections (UNIFORM): a systematic review and Delphi survey. Clinical Microbiology and Infection, 30 (4), 453-461. doi: 10.1016/j.cmi.2023.12.030

Peri, Anna Maria, Harris, Patrick N. A. and Paterson, David L. (2024). Host response signature trends in bacteraemia–authors’ response. Infectious Diseases, 56 (5), 1-3. doi: 10.1080/23744235.2024.2326591

Ling, Weiping, Paterson, David L., Harris, Patrick N. A., Furuya-Kanamori, Luis, Edwards, Felicity and Laupland, Kevin B. (2024). Mortality, hospital length of stay and recurrent bloodstream infections associated with extended-spectrum beta-lactamase producing Escherichia coli (ESBL-Ec) in a low prevalence region: a 20-year population-based large cohort study. International Journal of Infectious Diseases, 138, 84-90. doi: 10.1016/j.ijid.2023.11.007

Peri, Anna Maria, Rafiei, Nastaran, O’Callaghan, Kevin, Brischetto, Anna, Graves, Bianca, Sinclair, Holly, Eustace, Matthew, Lim, Karen, Parkes-Smith, Jill, Stewart, Adam, Davidson, Natalie, Tabah, Alexis, Bergh, Haakon, Chatfield, Mark D., Harris, Patrick N. A. and Paterson, David L. (2023). Host response signature trends in persistent bacteraemia and metastatic infection due to Staphylococcus aureus and Gram-negative bacilli: a prospective multicentre observational study. Infectious Diseases, 56 (4), 268-276. doi: 10.1080/23744235.2023.2294122

Delgarm Shams-Abadi, Ali, Mohammadian-Hafshejani, Abdollah, Paterson, David L., Arash, Rezvan, Asadi Farsani, Elham, Taji, Asieh, Heidari, Hamid and Shahini Shams Abadi, Milad (2023). The prevalence of colistin resistance in clinical Stenotrophomonas maltophilia isolates worldwide: a systematic review and meta-analysis. BMC Microbiology, 23 (1) 200. doi: 10.1186/s12866-023-02950-6

Peri, Anna Maria, Edwards, Felicity, Henden, Andrea, Harris, Patrick N. A., Chatfield, Mark D., Paterson, David L. and Laupland, Kevin B. (2023). Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years. Clinical and Experimental Medicine, 23 (8), 4563-4573. doi: 10.1007/s10238-023-01206-x

Aslan, Abdullah Tarık, Ezure, Yukiko, Horcajada, Juan Pablo, Harris, Patrick N. A. and Paterson, David L. (2023). In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review. Frontiers in Medicine, 10 1249030, 1-16. doi: 10.3389/fmed.2023.1249030

Boutzoukas, Angelique E., Komarow, Lauren, Chen, Liang, Hanson, Blake, Kanj, Souha S., Liu, Zhengyin, Salcedo Mendoza, Soraya, Ordoñez, Karen, Wang, Minggui, Paterson, David L., Evans, Scott, Ge, Lizhao, Giri, Abhigya, Hill, Carol, Baum, Keri, Bonomo, Robert A., Kreiswirth, Barry, Patel, Robin, Arias, Cesar A., Chambers, Henry F., Fowler, Vance G., van Duin, David and on behalf of the Antibacterial Resistance Leadership Group and Multi-Drug Resistant Organism Network Investigators (2023). International epidemiology of carbapenemase-producing Escherichia coli. Clinical Infectious Diseases, 77 (4), 499-509. doi: 10.1093/cid/ciad288

Mo, Yin, Ying, Ding, Cao, Yang, Hopkins, Jill, Ashley, Elizabeth A., Waithira, Naomi, Wannapinij, Prapass, Lee, Sue J., Paterson, David L., Doorn, H. Rogier van and Turner, Paul (2023). ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance. Wellcome Open Research, 8 179, 179. doi: 10.12688/wellcomeopenres.19210.2

Denny, Kerina J., Lea, Rodney A., Lindell-Innes, Ross, Haupt, Larisa M., Heffernan, Aaron J., Harvey, Nicholas R., Hughes, Oliver, Cao, Van T., Stuart, Janine, Paterson, David L., McNamara, John F., Ungerer, Jacobus P.J., Pretorius, Carel J., Griffiths, Lyn R. and Lipman, Jeffrey (2023). Diagnosing sepsis in the ICU: comparison of a gene expression signature to pre-existing biomarkers. Journal of Critical Care, 76 154286, 1-6. doi: 10.1016/j.jcrc.2023.154286

Stewart, Adam G., Heney, Claire, Paterson, David L., Harris, Patrick N.A., Edwards, Felicity and Laupland, Kevin B. (2023). Scedosporium species and Lomentospora prolificans fungaemia is uniformly fatal in patients with haematological malignancy. Internal Medicine Journal, 53 (8), 1489-1491. doi: 10.1111/imj.16198

Lian, Zheng Jie, Phan, Minh-Duy, Hancock, Steven J., Nhu, Nguyen Thi Khanh, Paterson, David L. and Schembri, Mark A. (2023). Genetic basis of I-complex plasmid stability and conjugation. PLoS Genetics, 19 (6) e1010773, 1-21. doi: 10.1371/journal.pgen.1010773

Stewart, Adam G., Chen, Sharon C.-A., Hamilton, Kate, Harris-Brown, Tiffany, Korman, Tony M., Figtree, Melanie, Worth, Leon J., Kok, Jen, Van der Poorten, David, Byth, Karen, Slavin, Monica A. and Paterson, David L. (2023). Clostridioides difficile infection: clinical practice and health outcomes in six large tertiary hospitals in Eastern Australia. Open Forum Infectious Diseases, 10 (6) ofad232, ofad232. doi: 10.1093/ofid/ofad232

Isler, Burcu, Aslan, Abdullah Tarık, Benli, Burhan Sami, Paterson, David L., Daneman, Nick, Fowler, Robert and Akova, Murat (2023). Duration of antibiotic treatment and timing of oral switching for bloodstream infections: a survey on the practices of infectious diseases and intensive care physicians. International Journal of Antimicrobial Agents, 61 (6) 106802, 1-5. doi: 10.1016/j.ijantimicag.2023.106802

Permana, Budi, Harris, Patrick N. A., Runnegar, Naomi, Lindsay, Margaret, Henderson, Belinda C., Playford, E. G., Paterson, David L., Beatson, Scott A. and Forde, Brian M. (2023). Using genomics to investigate an outbreak of vancomycin-resistant Enterococcus faecium ST78 at a large tertiary hospital in Queensland. Microbiology Spectrum, 11 (3) e0420422, 1-10. doi: 10.1128/spectrum.04204-22

Laupland, Kevin B., Edwards, Felicity, Furuya-Kanamori, Luis, Paterson, David L. and Harris, Patrick N. A. (2023). Bloodstream infection and colorectal cancer risk in Queensland Australia, 2000-2019. The American Journal of Medicine, 136 (9), 896-901. doi: 10.1016/j.amjmed.2023.05.003

Stewart, Adam G., Bauer, Michelle J., Butkiewicz, Dominika, Hinton, Alexandra, Henderson, Andrew, Harris, Patrick N.A. and Paterson, David L. (2023). In vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial. International Journal of Antimicrobial Agents, 62 (2) 106858, 1-4. doi: 10.1016/j.ijantimicag.2023.106858

Shields, Ryan K., Paterson, David L. and Tamma, Pranita D. (2023). Navigating available treatment options for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex infections. Clinical Infectious Diseases, 76 (Supplement_2), S179-S193. doi: 10.1093/cid/ciad094

Walczak, Andrew, McCarthy, Kate and Paterson, David L. (2023). A contemporary case series of Pseudomonas aeruginosa infective endocarditis. Medicine, 102 (13) e32662, 1-5. doi: 10.1097/md.0000000000032662

Laupland, Kevin B., Edwards, Felicity, Harris, Patrick N. A. and Paterson, David L. (2023). Significant clinical differences but not outcomes between Klebsiella aerogenes and Enterobacter cloacae bloodstream infections: a comparative cohort study. Infection, 51 (5), 1445-1451. doi: 10.1007/s15010-023-02010-1

Ling, Weiping, Paterson, David L., Harris, Patrick N. A., Furuya-Kanamori, Luis, Edwards, Felicity and Laupland, Kevin B. (2023). Population-based incidence and characteristics of adult Escherichia coli bloodstream infection in Queensland, Australia from 2000 to 2019. Open Forum Infectious Diseases, 10 (3) ofad071, ofad071. doi: 10.1093/ofid/ofad071

Schults, Jessica, Edwards, Felicity, Charles, Karina, Irwin, Adam D., Rickard, Claire M., Harris, Patrick N. A., Paterson, David L. and Laupland, Kevin (2023). Evolving insights into the epidemiology of Moraxella species bloodstream infection from two decades of surveillance in Queensland, Australia. European Journal of Clinical Microbiology and Infectious Diseases, 42 (2), 209-216. doi: 10.1007/s10096-022-04540-2

Isler, Burcu, Falconer, Caitlin, Vatansever, Cansel, Özer, Berna, Çınar, Güle, Aslan, Abdullah Tarık, Forde, Brian, Harris, Patrick, Şimşek, Funda, Tülek, Necla, Demirkaya, Hamiyet, Menekşe, Şirin, Akalin, Halis, Balkan, İlker İnanç, Aydın, Mehtap, Tigen, Elif Tükenmez, Demir, Safiye Koçulu, Kapmaz, Mahir, Keske, Şiran, Doğan, Özlem, Arabacı, Çiğdem, Yağcı, Serap, Hazırolan, Gülşen, Bakır, Veli Oğuzalp, Gönen, Mehmet, Saltoğlu, Neşe, Azap, Alpay, Azap, Özlem, Akova, Murat ... Paterson, David L. (2022). High prevalence of ArmA-16S rRNA methyltransferase among aminoglycoside-resistant Klebsiella pneumoniae bloodstream isolates. Journal of Medical Microbiology, 71 (12) 001629, 1-8. doi: 10.1099/jmm.0.001629

Griskaitis, Matas, Furuya-Kanamori, Luis, Allel, Kasim, Stabler, Richard, Harris, Patrick, Paterson, David L. and Yakob, Laith (2022). β-lactam-resistant Streptococcus pneumoniae dynamics following treatment: a dose-response meta-analysis. Clinical Infectious Diseases, 75 (11), 1962-1970. doi: 10.1093/cid/ciac293

Tong, Steven Y. C., Mora, Jocelyn, Bowen, Asha C., Cheng, Matthew P., Daneman, Nick, Goodman, Anna L., Heriot, George S., Lee, Todd C., Lewis, Roger J., Lye, David C., Mahar, Robert K., Marsh, Julie, McGlothlin, Anna, McQuilten, Zoe, Morpeth, Susan C., Paterson, David L., Price, David J., Roberts, Jason A., Robinson, J Owen, van Hal, Sebastiaan J., Walls, Genevieve, Webb, Steve A., Whiteway, Lyn, Yahav, Dafna and Davis, Joshua S. (2022). The Staphylococcus aureus Network Adaptive Platform trial protocol: new tools for an old foe. Clinical Infectious Diseases, 75 (11), 2027-2034. doi: 10.1093/cid/ciac476

Lee, I. Russel, Tong, Steven Y. C., Davis, Joshua S., Paterson, David L., Syed-Omar, Sharifah F., Peck, Kwong Ran, Chung, Doo Ryeon, Cooke, Graham S., Libau, Eshele Anak, Rahman, Siti-Nabilah B. A., Gandhi, Mihir P., Shi, Luming, Zheng, Shuwei, Chaung, Jenna, Tan, Seow Yen, Kalimuddin, Shirin, Archuleta, Sophia and Lye, David C. (2022). Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial. Trials, 23 (1) 572, 1-18. doi: 10.1186/s13063-022-06495-3

Aslan, Abdullah Tarık, Akova, Murat and Paterson, David L. (2022). Next-generation polymyxin class of antibiotics: a ray of hope illuminating a dark road. Antibiotics, 11 (12) 1711, 1-17. doi: 10.3390/antibiotics11121711

Johns, Brenton P., Dewar, David C., Loewenthal, Mark R., Manning, Laurens A., Atrey, Amit, Atri, Nipun, Campbell, David G., Dunbar, Michael, Kandel, Christopher, Khoshbin, Amir, Jones, Christopher W., Lora-Tamayo, Jaime, McDougall, Catherine, Moojen, Dirk Jan F., Mulford, Jonathan, Paterson, David L., Peel, Trisha, Solomon, Michael, Young, Simon W. and Davis, Joshua S. (2022). A desirability of outcome ranking (DOOR) for periprosthetic joint infection – a Delphi analysis. Journal of Bone and Joint Infection, 7 (6), 221-229. doi: 10.5194/jbji-7-221-2022

Laupland, Kevin B., Harris, Patrick N. A., Stewart, Adam G., Edwards, Felicity and Paterson, David L. (2022). Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections. Diagnostic Microbiology and Infectious Disease, 104 (3) 115772, 1-5. doi: 10.1016/j.diagmicrobio.2022.115772

Bauer, Michelle J., Peri, Anna Maria, Lüftinger, Lukas, Beisken, Stephan, Bergh, Haakon, Forde, Brian M., Buckley, Cameron, Cuddihy, Thom, Tan, Patrice, Paterson, David L., Whiley, David M. and Harris, Patrick N. A. (2022). Optimized method for bacterial nucleic acid extraction from positive blood culture broth for whole-genome sequencing, resistance phenotype prediction, and downstream molecular applications. Journal of Clinical Microbiology, 60 (11) e01012-22, 1-11. doi: 10.1128/jcm.01012-22

Ling, Weiping, Cadavid-Restrepo, Angela, Furuya-Kanamori, Luis, Harris, Patrick N.A. and Paterson, David L. (2022). Incidence and predictors of Escherichia coli producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia from 2010 to 2019: a population-based spatial analysis. Epidemiology and Infection, 150 e178, 1-27. doi: 10.1017/s0950268822001637

Peri, Anna Maria, Ling, Weiping, Furuya-Kanamori, Luis, Harris, Patrick N. A. and Paterson, David L. (2022). Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies. BMC Infectious Diseases, 22 (1) 794, 1-14. doi: 10.1186/s12879-022-07772-x

Edwards, Felicity, Glen, Kate, Harris, Patrick N. A., Paterson, David L. and Laupland, Kevin B. (2022). Determinants and outcomes of bloodstream infections related to obesity. European Journal of Clinical Microbiology and Infectious Diseases, 41 (11), 1347-1353. doi: 10.1007/s10096-022-04501-9

Stewart, Adam G., Isler, Burcu and Paterson, David L. (2022). An Australian perspective on antimicrobial stewardship programs and transplantation. Transplant Infectious Disease, 24 (5) e13912, 1-4. doi: 10.1111/tid.13912

Ranasinghe, Ama, Henderson, Andrew, Cottrell, Kyra, Tan, Cindy S. E., Burnard, Delaney, Kato, Hideo, Paterson, David L. and Harris, Patrick N. A. (2022). Determining the in vitro susceptibility of tebipenem, an oral carbapenem, against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolated from bloodstream infections. JAC-Antimicrobial Resistance, 4 (5) dlac105, 1-6. doi: 10.1093/jacamr/dlac105

Browning, Sarah, Manning, Laurens, Metcalf, Sarah, Paterson, David L., Robinson, James O., Clark, Benjamin and Davis, Joshua S. (2022). Characteristics and outcomes of culture-negative prosthetic joint infections from the Prosthetic Joint Infection in Australia and New Zealand Observational (PIANO) cohort study. Journal of Bone and Joint Infection, 7 (5), 203-211. doi: 10.5194/jbji-7-203-2022

Blaskovich, Mark A.T., Hansford, Karl A., Butler, Mark S., Ramu, Soumya, Kavanagh, Angela M., Jarrad, Angie M., Prasetyoputri, Anggia, Pitt, Miranda E., Huang, Johnny X., Lindahl, Fredrik, Ziora, Zyta M., Bradford, Tanya, Muldoon, Craig, Rajaratnam, Premraj, Pelingon, Ruby, Edwards, David J., Zhang, Bing, Amado, Maite, Elliott, Alysha G., Zuegg, Johannes, Coin, Lachlan, Woischnig, Anne-Kathrin, Khanna, Nina, Breidenstein, Elena, Stincone, Anna, Mason, Clive, Khan, Nawaz, Cho, Hye-Kyung, Karau, Melissa J. ... Cooper, Matthew A. (2022). A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections. Science Translational Medicine, 14 (662) abj2381, 1-16. doi: 10.1126/scitranslmed.abj2381

Blaskovich, Mark A.T., Hansford, Karl A., Butler, Mark S., Ramu, Soumya, Kavanagh, Angela M., Jarrad, Angie M., Prasetyoputri, Anggia, Pitt, Miranda E., Huang, Johnny X., Lindahl, Fredrik, Ziora, Zyta M., Bradford, Tanya, Muldoon, Craig, Rajaratnam, Premraj, Pelingon, Ruby, Edwards, David J., Zhang, Bing, Amado, Maite, Elliott, Alysha G., Zuegg, Johannes, Coin, Lachlan, Woischnig, Anne-Kathrin, Khanna, Nina, Breidenstein, Elena, Stincone, Anna, Mason, Clive, Khan, Nawaz, Cho, Hye-Kyung, Karau, Melissa J. ... Cooper, Matthew A. (2022). A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections. Science Translational Medicine, 14 (662) abj2381. doi: 10.1126/scitranslmed.abj238

Forde, Brian M., Bergh, Haakon, Cuddihy, Thom, Hajkowicz, Krispin, Hurst, Trish, Playford, E Geoffrey, Henderson, Belinda C., Runnegar, Naomi, Clark, Julia, Jennison, Amy V., Moss, Susan, Hume, Anna, Leroux, Hugo, Beatson, Scott A., Paterson, David L. and Harris, Patrick N. A. (2022). Clinical implementation of routine whole-genome sequencing for hospital infection control of multi-drug resistant pathogens. Clinical Infectious Diseases, 76 (3), e1277-e1284. doi: 10.1093/cid/ciac726

Isler, Burcu, Vatansever, Cansel, Özer, Berna, Çınar, Güle, Aslan, Abdullah Tarık, Stewart, Adam, Simos, Peter, Falconer, Caitlin, Bauer, Michelle J., Forde, Brian, Harris, Patrick, Şimşek, Funda, Tülek, Necla, Demirkaya, Hamiyet, Menekşe, Şirin, Akalin, Halis, Balkan, İlker İnanç, Aydın, Mehtap, Tigen, Elif Tükenmez, Demir, Safiye Koçulu, Kapmaz, Mahir, Keske, Şiran, Doğan, Özlem, Arabacı, Çiğdem, Yağcı, Serap, Hazırolan, Gülşen, Bakır, Veli Oğuzalp, Gönen, Mehmet, Saltoğlu, Neşe ... Can, Füsun (2022). Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates. Diagnostic Microbiology and Infectious Disease, 104 (1) 115745, 1-4. doi: 10.1016/j.diagmicrobio.2022.115745

Hernández-Mitre, María Patricia, Tong, Steven Y. C., Denholm, Justin T., Dore, Gregory J., Bowen, Asha C., Lewin, Sharon R., Venkatesh, Balasubramanian, Hills, Thomas E., McQuilten, Zoe, Paterson, David L., Morpeth, Susan C. and Roberts, Jason A. (2022). Nafamostat mesylate for treatment of COVID-19 in hospitalised patients: a structured, narrative review. Clinical Pharmacokinetics, 61 (10), 1331-1343. doi: 10.1007/s40262-022-01170-x

Ayfan, Abdulrahman K. S., Macdonald, Joanne, Irwin, Adam D., Zowawi, Hosam M., Forde, Brian M., Paterson, David L., Lahra, Monica M. and Whiley, David M. (2022). Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility. Journal of Antimicrobial Chemotherapy, 77 (11), 2933-2936. doi: 10.1093/jac/dkac242

Isler, Burcu, Paterson, David L., Harris, Patrick N. A., Ling, Weiping, Edwards, Felicity, Rickard, Claire M., Kidd, Timothy J., Gassiep, Ian and Laupland, Kevin B. (2022). Achromobacter species: an emerging cause of community-onset bloodstream infections. Microorganisms, 10 (7) 1449, 1-9. doi: 10.3390/microorganisms10071449

Paterson, David L., Bassetti, Matteo, Motyl, Mary, Johnson, Matthew G., Castanheira, Mariana, Jensen, Erin H., Huntington, Jennifer A., Yu, Brian, Wolf, Dominik J. and Bruno, Christopher J. (2022). Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial. Journal of Antimicrobial Chemotherapy, 77 (9), 2522-2531. doi: 10.1093/jac/dkac184

Peri, Anna Maria, Bauer, Michelle J., Bergh, Haakon, Butkiewicz, Dominika, Paterson, David L. and Harris, Patrick N. A. (2022). Performance of the BioFire Blood Culture Identification 2 Panel for the diagnosis of bloodstream infections. Heliyon, 8 (7) e09983, 1-6. doi: 10.1016/j.heliyon.2022.e09983

Manning, Laurens, Metcalf, Sarah, Dymock, Michael, Robinson, Owen, Clark, Benjamin, Nelson, Renjy, Paterson, David L., Yates, Piers, Loewenthal, Mark, Dewar, David, Huggan, Paul and Davis, Joshua S. (2022). Short- versus standard-course intravenous antibiotics for peri-prosthetic joint infections managed with debridement and implant retention: a randomised pilot trial using a desirability of outcome ranking (DOOR) endpoint. International Journal of Antimicrobial Agents, 60 (1) 106598, 1-9. doi: 10.1016/j.ijantimicag.2022.106598

Ling, Weiping, Peri, Anna Maria, Furuya-Kanamori, Luis, Harris, Patrick N.A. and Paterson, David L. (2022). Carriage duration and household transmission of Enterobacterales producing extended-spectrum beta-lactamase in the community: a systematic review and meta-analysis. Microbial Drug Resistance, 28 (7), 1-11. doi: 10.1089/mdr.2022.0035

Burnard, Delaney, Bauer, Michelle J., Falconer, Caitlin, Gassiep, Ian, Norton, Robert E., Paterson, David L. and Harris, Patrick NA (2022). Clinical Burkholderia pseudomallei isolates from north Queensland carry diverse bimABm genes that are associated with central nervous system disease and are phylogenomically distinct from other Australian strains. PLoS Neglected Tropical Diseases, 16 (6) e0009482, 1-12. doi: 10.1371/journal.pntd.0009482

Laupland, Kevin B., Paterson, David L., Stewart, Adam G., Edwards, Felicity and Harris, Patrick N. A. (2022). Sphingomonas paucimobilis bloodstream infection is a predominantly community-onset disease with significant lethality. International Journal of Infectious Diseases, 119, 172-177. doi: 10.1016/j.ijid.2022.03.060

Babich, Tanya, Naucler, Pontus, Valik, John Karlsson, Giske, Christian G., Benito, Natividad, Cardona, Ruben, Rivera, Alba, Pulcini, Celine, Fattah, Manal Abdel, Haquin, Justine, Macgowan, Alasdair, Grier, Sally, Chazan, Bibiana, Yanovskay, Anna, Ami, Ronen Ben, Landes, Michal, Nesher, Lior, Zaidman-Shimshovitz, Adi, McCarthy, Kate, Paterson, David L., Tacconelli, Evelina, Buhl, Michael, Mauer, Susanna, Rodríguez-Baño, Jesús, de Cueto, Marina, Oliver, Antonio, de Gopegui, Enrique Ruiz, Cano, Angela, Machuca, Isabel ... Yahav, Dafna (2022). Duration of treatment for Pseudomonas aeruginosa bacteremia: a retrospective study. Infectious Diseases and Therapy, 11 (4), 1505-1519. doi: 10.1007/s40121-022-00657-1

Falconer, Nazanin, Paterson, David L., Peel, Nancye, Welch, Alyssa, Freeman, Christopher, Burkett, Ellen, Hubbard, Ruth, Comans, Tracy, Hanjani, Leila Shafiee, Pascoe, Elaine, Hawley, Carmel and Gray, Leonard (2022). A multimodal intervention to optimise antimicrobial use in residential aged care facilities (ENGAGEMENT): protocol for a stepped-wedge cluster randomised trial. Trials, 23 (1) 427. doi: 10.1186/s13063-022-06323-8

Kwok, Michael, McGeorge, Stephen, Mayer‐Coverdale, Johanna, Graves, Bianca, Paterson, David L., Harris, Patrick N.A., Esler, Rachel, Dowling, Caroline, Britton, Sumudu and Roberts, Matthew J. (2022). Guideline of guidelines: management of recurrent urinary tract infections in women. BJU International, 11 (2), 104-107. doi: 10.1111/bju.15756

Ezure, Yukiko, Rico, Veronica, Paterson, David L., Hall, Lisa, Harris, Patrick N. A., Soriano, Alex, Roberts, Jason A., Bassetti, Matteo, Roberts, Matthew J., Righi, Elda and Wright, Hugh (2022). Efficacy and safety of carbapenems versus new antibiotics for treatment of adult patients with complicated urinary tract infections: a systematic review and meta-analysis. Open Forum Infectious Diseases, 9 (5) ofaa480, ofaa480. doi: 10.1093/ofid/ofaa480

Laupland, Kevin B., Paterson, David L., Edwards, Felicity, Stewart, Adam G. and Harris, Patrick N. A. (2022). Morganella morganii, an emerging cause of bloodstream infections. Microbiology Spectrum, 10 (3), e0056922. doi: 10.1128/spectrum.00569-22

Avent, Minyon L., McCarthy, Kate L., Sime, Fekade B., Naicker, Saiyuri, Heffernan, Aaron J., Wallis, Steven C., Paterson, David L. and Roberts, Jason A. (2022). Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model. Microbiology Spectrum, 10 (3), e0052522. doi: 10.1128/spectrum.00525-22

Schlebusch, Sanmarié, Graham, Rikki M. A., Jennison, Amy V., Lassig-Smith, Melissa M., Harris, Patrick N. A., Lipman, Jeffrey, Ó Cuív, Páraic and Paterson, David L. (2022). Standard rectal swabs as a surrogate sample for gut microbiome monitoring in intensive care. BMC Microbiology, 22 (1) 99, 1-14. doi: 10.1186/s12866-022-02487-0

Laupland, Kevin B, Stewart, Adam G, Edwards, Felicity, Paterson, David L, Coulter, Sonali, Heney, Claire, George, Narelle and Harris, Patrick (2022). Shewanella spp. bloodstream infections in Queensland, Australia. Emerging Infectious Diseases, 28 (4), 701-706. doi: 10.3201/eid2804.212193

De Oliveira, David M. P., Keller, Bernhard, Hayes, Andrew J., Ong, Cheryl-Lynn Y., Harbison-Price, Nichaela, El-Deeb, Ibrahim M., Li, Gen, Keller, Nadia, Bohlmann, Lisa, Brouwer, Stephan, Turner, Andrew G., Cork, Amanda J., Jones, Thomas R., Paterson, David L., McEwan, Alastair G., Davies, Mark R., McDevitt, Christopher A., Itzstein, Mark von and Walker, Mark J. (2022). Neurodegenerative disease treatment drug PBT2 breaks intrinsic polymyxin resistance in Gram-positive bacteria. Antibiotics, 11 (4) 449, 449. doi: 10.3390/antibiotics11040449

Isler, Burcu, Özer, Berna, Çınar, Güle, Aslan, Abdullah Tarık, Vatansever, Cansel, Falconer, Caitlin, Dolapçı, İştar, Şimşek, Funda, Tülek, Necla, Demirkaya, Hamiyet, Menekşe, Şirin, Akalin, Halis, Balkan, İlker İnanç, Aydın, Mehtap, Tigen, Elif Tükenmez, Demir, Safiye Koçulu, Kapmaz, Mahir, Keske, Şiran, Doğan, Özlem, Arabacı, Çiğdem, Yağcı, Serap, Hazırolan, Gülşen, Bakır, Veli Oğuzalp, Gönen, Mehmet, Chatfield, Mark D., Forde, Brian, Saltoğlu, Neşe, Azap, Alpay, Azap, Özlem ... Ergönül, Önder (2022). Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting. European Journal of Clinical Microbiology and Infectious Diseases, 41 (5), 841-847. doi: 10.1007/s10096-022-04425-4

Wang, Minggui, Earley, Michelle, Chen, Liang, Hanson, Blake M., Yu, Yunsong, Liu, Zhengyin, Salcedo, Soraya, Cober, Eric, Li, Lanjuan, Kanj, Souha S., Gao, Hainv, Munita, Jose M., Ordoñez, Karen, Weston, Greg, Satlin, Michael J., Valderrama-Beltrán, Sandra L., Marimuthu, Kalisvar, Stryjewski, Martin E., Komarow, Lauren, Luterbach, Courtney, Marshall, Steve H., Rudin, Susan D., Manca, Claudia, Paterson, David L., Reyes, Jinnethe, Villegas, Maria V., Evans, Scott, Hill, Carol, Arias, Rebekka ... van Duin, David (2022). Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. The Lancet. Infectious diseases, 22 (3), 401-412. doi: 10.1016/S1473-3099(21)00399-6

Davis, Joshua S., Metcalf, Sarah, Clark, Benjamin, Owen Robinson, J., Huggan, Paul, Luey, Chris, McBride, Stephen, Aboltins, Craig, Nelson, Renjy, Campbell, David, Solomon, L. Bogdan, Schneider, Kellie, Loewenthal, Mark R., Yates, Piers, Athan, Eugene, Cooper, Darcie, Rad, Babak, Allworth, Tony, Reid, Alistair, Read, Kerry, Leung, Peter, Sud, Archana, Nagendra, Vana, Chean, Roy, Lemoh, Chris, Mutalima, Nora, Tran, Ton, Grimwade, Kate, Sehu, Marjoree ... Manning, Laurens (2022). Predictors of treatment success after periprosthetic joint infection: 24-month follow up from a Multicenter Prospective Observational Cohort Study of 653 patients. Open Forum Infectious Diseases, 9 (3) ofac048, 1-9. doi: 10.1093/ofid/ofac048

Laupland, Kevin B., Stewart, Adam G., Edwards, Felicity, Harris, Patrick, Heney, Claire, George, Narelle, Coulter, Sonali and Paterson, David L. (2022). Pasteurella species bloodstream infections in Queensland, Australia, 2000–2019. European Journal of Clinical Microbiology and Infectious Diseases, 41 (4), 609-614. doi: 10.1007/s10096-022-04411-w

Rickard, Claire M., Paterson, David L. and Chopra, Vineet (2022). For and against routine removal of peripheral intravenous catheters. JAMA Internal Medicine, 182 (4), 456-457. doi: 10.1001/jamainternmed.2021.8304

Paterson, David L., Kinoshita, Masahiro, Baba, Takamichi, Echols, Roger and Portsmouth, Simon (2022). Outcomes with Cefiderocol treatment in patients with bacteraemia enrolled into prospective Phase 2 and Phase 3 randomised clinical studies. Infectious Diseases and Therapy, 11 (2), 853-870. doi: 10.1007/s40121-022-00598-9

Davis, Joshua S., Metcalf, Sarah, Paterson, David L., Robinson, James O., Clarke, Benjamin and Manning, Laurens (2022). Proposed empiric antibiotic therapy for prosthetic joint infections: an analysis of the Prosthetic Joint Infection in Australia and New Zealand, Observational (PIANO) cohort. Internal Medicine Journal, 52 (2), 322-325. doi: 10.1111/imj.15677

McNamara, John F, Harris, Patrick NA, Chatfield, Mark D and Paterson, David L (2022). Long term sepsis readmission, mortality and cause of death following Gram negative bloodstream infection: a propensity matched observational linkage study. International Journal of Infectious Diseases, 114, 34-44. doi: 10.1016/j.ijid.2021.10.047

Phan, Minh-Duy, Peters, Kate M., Alvarez Fraga, Laura, Wallis, Steven C., Hancock, Steven, Nhu, Nguyen Thi Khanh, Forde, Brian, Bauer, Michelle J., Paterson, David L., Beatson, Scott A, Lipman, Jeffrey and Schembri, Mark A. (2022). Plasmid-mediated ciprofloxacin resistance imparts a selective advantage on Escherichia coli ST131. Antimicrobial Agents and Chemotherapy, 66 (1) e02146-21, 1-11. doi: 10.1128/aac.02146-21

Tait, Jessica R., Bilal, Hajira, Rogers, Kate E., Lang, Yinzhi, Kim, Tae-Hwan, Zhou, Jieqiang, Wallis, Steven C., Bulitta, Jürgen B., Kirkpatrick, Carl M. J., Paterson, David L., Lipman, Jeffrey, Bergen, Phillip J., Roberts, Jason A., Nation, Roger L. and Landersdorfer, Cornelia B. (2022). Effect of different Piperacillin-Tazobactam dosage regimens on synergy of the combination with Tobramycin against Pseudomonas aeruginosa for the pharmacokinetics of critically ill patients in a dynamic infection model. Antibiotics, 11 (1) 101, 101. doi: 10.3390/antibiotics11010101

Lodise, Thomas P., Bassetti, Matteo, Ferrer, Ricard, Naas, Thierry, Niki, Yoshihito, Paterson, David L., Zeitlinger, Markus and Echols, Roger (2022). All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies. Expert Review of Anti-Infective Therapy, 20 (5), 707-719. doi: 10.1080/14787210.2022.2020099

Peri, Anna Maria, Bauer, Michelle J., Bergh, Haakon, Butkiewicz, Dominika, Paterson, David L. and Harris, Patrick N.A. (2022). Performance of the BioFire Blood Culture Identification 2 Panel for the diagnosis of bloodstream infections on blood cultures from the intensive care unit and emergency department. SSRN Electronic Journal. doi: 10.2139/ssrn.4003859

Isler, Burcu, Aslan, Abdullah Tarık, Akova, Murat, Harris, Patrick and Paterson, David L. (2022). Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections. Expert Review of Anti-Infective Therapy, 20 (11), 1389-1400. doi: 10.1080/14787210.2022.2128764

Kwok, Michael, Yaxley, William, Ranasinghe, Sachinka, Morton, Leanne, Perera, Sachin, Ponen, Kreyen, Pelecanos, Anita, Britton, Sumudu, Harris, Patrick N. A., Paterson, David L., Esler, Rachel, Hussey, David, Yaxley, John W. and Roberts, Matthew J. (2022). Determining risk factors for symptomatic urinary tract infection following trial of void: A retrospective analysis. Journal of Clinical Urology, 205141582210998. doi: 10.1177/20514158221099856

Stewart, Adam G, Henderson, Andrew, Bauer, Michelle J, Paterson, David L and Harris, Patrick N A (2021). Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial. JAC-Antimicrobial Resistance, 4 (1) dlab192, dlab192. doi: 10.1093/jacamr/dlab192

Stewart, Adam G., Harris, Patrick N. A., Chatfield, Mark D., Littleford, Roberta and Paterson, David L. (2021). Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales (“MERINO-3”): study protocol for a multicentre, open-label randomised non-inferiority trial. Trials, 22 (1) 301, 301. doi: 10.1186/s13063-021-05206-8

Axfors, Cathrine, Janiaud, Perrine, Schmitt, Andreas M., van’t Hooft, Janneke, Smith, Emily R., Haber, Noah A., Abayomi, Akin, Abduljalil, Manal, Abdulrahman, Abdulkarim, Acosta-Ampudia, Yeny, Aguilar-Guisado, Manuela, Al-Beidh, Farah, Alejandria, Marissa M., Alfonso, Rachelle N., Ali, Mohammad, AlQahtani, Manaf, AlZamrooni, Alaa, Anaya, Juan-Manuel, Ang, Mark Angelo C., Aomar, Ismael F., Argumanis, Luis E., Averyanov, Alexander, Baklaushev, Vladimir P., Balionis, Olga, Benfield, Thomas, Berry, Scott, Birocco, Nadia, Bonifacio, Lynn B., Bowen, Asha C. ... Hemkens, Lars G. (2021). Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials. BMC Infectious Diseases, 21 (1) 1170, 1170. doi: 10.1186/s12879-021-06829-7

Henderson, Andrew, Bursle, Evan, Stewart, Adam, Harris, Patrick N. A., Paterson, David, Chatfield, Mark D., Paul, Mical, Dickstein, Yaakov, Rodriguez-Baño, Jesus, Turnidge, John D. and Kahlmeter, Gunnar (2021). A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to Gram negative pathogens. Intended category: systematic review. Clinical Microbiology and Infection, 27 (12), 1746-1753. doi: 10.1016/j.cmi.2021.03.019

Wright, Hugh, Harris, Patrick N. A., Chatfield, Mark D., Lye, David, Henderson, Andrew, Harris-Brown, Tiffany, Donaldson, Anna and Paterson, David L. (2021). Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial. Trials, 22 (1) 889. doi: 10.1186/s13063-021-05870-w

Paterson, David L. and Rickard, Claire M. (2021). Letter from Australia: a never-ending pandemic?. Annals of Internal Medicine, 174 (12), 1743-1744. doi: 10.7326/m21-3295

Peri, Anna Maria, Harris, Patrick N. A. and Paterson, David L. (2021). Culture-independent detection systems for bloodstream infection. Clinical Microbiology and Infection, 28 (2), 195-201. doi: 10.1016/j.cmi.2021.09.039

Isler, Burcu, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2021). An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa–—authors’ response. Journal of Antimicrobial Chemotherapy, 76 (12), 3327-3328. doi: 10.1093/jac/dkab366

Ling, Weiping, Furuya-Kanamori, Luis, Ezure, Yukiko, Harris, Patrick N. A. and Paterson, David L. (2021). Adverse clinical outcomes associated with carbapenem-resistant Acinetobacter (CRA) infections: a systematic review and meta-analysis. JAC-Antimicrobial Resistance, 3 (4) dlab157, 1-12. doi: 10.1093/jacamr/dlab157

Wen, Sophie C. H., Ezure, Yukiko, Rolley, Lauren, Spurling, Geoff, Lau, Colleen L., Riaz, Saba, Paterson, David L. and Irwin, Adam D. (2021). Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis. PLoS Medicine, 18 (9) e1003787, 1-20. doi: 10.1371/journal.pmed.1003787

Russo, Alessandro, Paterson, David L. and Bassetti, Matteo (2021). Editorial: spotlight on the relationship between sepsis and infection: from mechanisms to therapy. Frontiers in Medicine, 8 716215, 716215. doi: 10.3389/fmed.2021.716215

Stewart, Adam G., Paterson, David L., Young, Barnaby, Lye, David C, Davis, Joshua S., Schneider, Kellie, Yilmaz, Mesut, Dinleyici, Rumeysa, Runnegar, Naomi, Henderson, Andrew, Archuleta, Sophia, Kalimuddin, Shirin, Forde, Brian M., Chatfield, Mark D., Bauer, Michelle J., Lipman, Jeffrey, Harris-Brown, Tiffany, Harris, Patrick N. A. and for the MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN) (2021). Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC beta-lactamase producing Enterobacter spp., Citrobacter freundii, Morganella morganii, Providencia spp., or Serratia marcescens: a pilot multi-center randomized controlled trial (MERINO-2). Open Forum Infectious Diseases, 8 (8) ofab387, ofab387. doi: 10.1093/ofid/ofab387

Babich, Tanya, Naucler, Pontus, Valik, John Karlsson, Giske, Christian G, Benito, Natividad, Cardona, Ruben, Rivera, Alba, Pulcini, Celine, Abdel Fattah, Manal, Haquin, Justine, MacGowan, Alasdair, Grier, Sally, Gibbs, Julie, Chazan, Bibiana, Yanovskay, Anna, Ami, Ronen Ben, Landes, Michal, Nesher, Lior, Zaidman-Shimshovitz, Adi, McCarthy, Kate, Paterson, David L, Tacconelli, Evelina, Buhl, Michael, Mauer, Susanna, Rodriguez-Bano, Jesus, Morales, Isabel, Oliver, Antonio, Ruiz De Gopegui, Enrique, Cano, Angela ... Yahav, Dafna (2021). Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study. Journal of Antimicrobial Chemotherapy, 76 (8), 2172-2181. doi: 10.1093/jac/dkab134

Huber, Charlotte A., Reed, Sarah J. and Paterson, David L. (2021). Bacterial sub-species typing using matrix-assisted laser desorption/ionization time of flight mass spectrometry: what is promising?. Current Issues in Molecular Biology, 43 (2), 749-757. doi: 10.3390/cimb43020054

McCarthy, K. L., Harris-Brown, T., Smits, E. J., Legg, A., Chatfield, M. D. and Paterson, D. L. (2021). The MOBILISE study: utilisation of ambulatory pumps in the inpatient setting to administer continuous antibiotic infusions—a randomised controlled trial. European Journal of Clinical Microbiology & Infectious Diseases, 40 (12), 2505-2513. doi: 10.1007/s10096-021-04294-3

Stewart, Adam G., Cottrell, Kyra, Henderson, Andrew, Vemuri, Kanthi, Bauer, Michelle J., Paterson, David L. and Harris, Patrick N. A. (2021). In vitro activity of Cefotetan against ESBL-producing Escherichia coli and Klebsiella pneumoniae bloodstream isolates from the MERINO Trial. Microbiology Spectrum, 9 (1) e00226-21, 1-6. doi: 10.1128/spectrum.00226-21

Murigneux, Valentine, Roberts, Leah W., Forde, Brian M., Phan, Minh-Duy, Nhu, Nguyen Thi Khanh, Irwin, Adam D., Harris, Patrick N. A., Paterson, David L., Schembri, Mark A., Whiley, David M. and Beatson, Scott A. (2021). MicroPIPE: validating an end-to-end workflow for high-quality complete bacterial genome construction. BMC Genomics, 22 (1) 474, 474. doi: 10.1186/s12864-021-07767-z

Irwin, Adam D., Coin, Lachlan J. M., Harris, Patrick N. A., Cotta, Menino Osbert, Bauer, Michelle J., Buckley, Cameron, Balch, Ross, Kruger, Peter, Meyer, Jason, Shekar, Kiran, Brady, Kara, Fourie, Cheryl, Sharp, Natalie, Vlad, Luminita, Whiley, David, Beatson, Scott A., Forde, Brian M., Paterson, David, Clark, Julia, Hajkowicz, Krispin, Raman, Sainath, Bialasiewicz, Seweryn, Lipman, Jeffrey, Schlapbach, Luregn J. and Roberts, Jason A. (2021). Optimising treatment outcomes for children and adults through rapid genome sequencing of sepsis pathogens. A study protocol for a prospective, multi-centre trial (DIRECT). Frontiers in Cellular and Infection Microbiology, 11 667680, 1-8. doi: 10.3389/fcimb.2021.667680

Fang, Ferric C., Benson, Constance A., Del Rio, Carlos, Edwards, Kathryn M., Fowler, Vance G., Fredricks, David N., Limaye, Ajit P., Murray, Barbara E., Naggie, Susanna, Pappas, Peter G., Patel, Robin, Paterson, David L., Pegues, David A., Petri, William A. and Schooley, Robert T. (2021). COVID-19-lessons learned and questions remaining. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72 (12), 2225-2240. doi: 10.1093/cid/ciaa1654

Stewart, Adam G., Satlin, Michael J., Schlebusch, Sanmarié, Isler, Burcu, Forde, Brian M., Paterson, David L. and Harris, Patrick N. A. (2021). Completing the picture - capturing the resistome in antibiotic clinical trials. Clinical Infectious Diseases, 72 (12), e1122-e1129. doi: 10.1093/cid/ciaa1877

Foster, Andrew L., Cutbush, Kenneth, Ezure, Yukiko, Schuetz, Michael A., Crawford, Ross and Paterson, David L. (2021). Cutibacterium acnes in shoulder surgery: a scoping review of strategies for prevention, diagnosis, and treatment. Journal of Shoulder and Elbow Surgery, 30 (6), 1410-1422. doi: 10.1016/j.jse.2020.11.011

Ayfan, Abdulrahman K. S., Macdonald, Joanne, Harris, Patrick N. A., Heney, Claire, Paterson, David L., Trembizki, Ella, Wang, Claire Y. T., Whiley, David M., Zowawi, Hosam M. and Irwin, Adam D. (2021). Rapid detection of NDM and VIM carbapenemase encoding genes by recombinase polymerase amplification and lateral flow–based detection. European Journal of Clinical Microbiology & Infectious Diseases, 40 (11), 2447-2453. doi: 10.1007/s10096-021-04267-6

Abdul Rahim, Nusaibah, Zhu, Yan, Cheah, Soon-Ee, Johnson, Matthew D., Yu, Heidi H., Sidjabat, Hanna E., Butler, Mark S., Cooper, Matthew A., Fu, Jing, Paterson, David L., Nation, Roger L., Boyce, John D., Creek, Darren J., Bergen, Phillip J., Velkov, Tony and Li, Jian (2021). Synergy of the polymyxin-chloramphenicol combination against New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae is predominately driven by chloramphenicol. ACS Infectious Diseases, 7 (6), 1584-1595. doi: 10.1021/acsinfecdis.0c00661

Ling, Weiping, Furuya-Kanamori, Luis, Ezure, Yukiko, Harris, Patrick N A and Paterson, David L (2021). Adverse clinical outcomes associated with infections by Enterobacterales producing ESBL (ESBL-E): a systematic review and meta-analysis. JAC-Antimicrobial Resistance, 3 (2) dlab068, dlab068. doi: 10.1093/jacamr/dlab068

Agyeman, Akosua A., Rogers, Kate E., Tait, Jessica R., Bergen, Phillip J., Kirkpatrick, Carl M., Wallis, Steven C., Bulitta, Jürgen B., Paterson, David L., Lipman, Jeffrey, Nation, Roger L., Roberts, Jason A. and Landersdorfer, Cornelia B. (2021). Evaluation of meropenem-ciprofloxacin combination dosage regimens for the pharmacokinetics of critically ill patients with augmented renal clearance. Clinical Pharmacology and Therapeutics, 109 (4), 1104-1115. doi: 10.1002/cpt.2191

Roberts, Leah W., Forde, Brian M., Hurst, Trish, Ling, Weiping, Nimmo, Graeme R., Bergh, Haakon, George, Narelle, Hajkowicz, Krispin, McNamara, John F., Lipman, Jeffrey, Permana, Budi, Schembri, Mark A., Paterson, David, Beatson, Scott A. and Harris, Patrick N. A. (2021). Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care. Microbial Genomics, 7 (3) 000530. doi: 10.1099/mgen.0.000530

Burnard, Delaney, Robertson, Gemma, Henderson, Andrew, Falconer, Caitlin, Bauer, Michelle J., Cottrell, Kyra, Gassiep, Ian, Norton, Robert, Paterson, David L. and Harris, Patrick N. A. (2021). Burkholderia pseudomallei clinical isolates are highly susceptible in vitro to cefiderocol, a siderophore cephalosporin. Antimicrobial Agents and Chemotherapy, 65 (2) e00685-20. doi: 10.1128/aac.00685-20

Bassetti, Matteo, Echols, Roger, Matsunaga, Yuko, Ariyasu, Mari, Doi, Yohei, Ferrer, Ricard, Lodise, Thomas P., Naas, Thierry, Niki, Yoshihito, Paterson, David L., Portsmouth, Simon, Torre-Cisneros, Julian, Toyoizumi, Kiichiro, Wunderink, Richard G. and Nagata, Tsutae D. (2021). Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. The Lancet Infectious Diseases, 21 (2), 226-240. doi: 10.1016/S1473-3099(20)30796-9

Kato, Hideo, Parker, Suzanne L., Roberts, Jason A., Hagihara, Mao, Asai, Nobuhiro, Yamagishi, Yuka, Paterson, David L. and Mikamo, Hiroshige (2021). Population pharmacokinetics analysis of amikacin initial dosing regimen in elderly patients. Antibiotics, 10 (2) 100, 1-13. doi: 10.3390/antibiotics10020100

Paterson, David L., Isler, Burcu and Harris, Patrick N. A. (2021). PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant Enterobacterales. JAC-Antimicrobial Resistance, 3 (1). doi: 10.1093/jacamr/dlab013

Stewart, Adam G. and Paterson, David L. (2021). How urgent is the need for new antifungals?. Expert Opinion on Pharmacotherapy, 22 (14), 1-14. doi: 10.1080/14656566.2021.1935868

Wen, Sophie C.H., Ezure, Yukiko, Rolley, Lauren, Spurling, Geoff, Lau, Colleen L., Paterson, David L. and Irwin, Adam D. (2021). Gram-Negative Neonatal Sepsis in Low- and Middle- Income Countries: How Appropriate are the WHO Recommended Empirical Sepsis Antibiotic Regimens? A Systematic Review and Meta-Analysis. SSRN Electronic Journal. doi: 10.2139/ssrn.3777180

Elliott, Thomas M., Harris, Patrick N., Roberts, Leah W., Doidge, Michelle, Hurst, Trish, Hajkowicz, Krispin, Forde, Brian, Paterson, David L. and Gordon, Louisa G. (2021). Cost-effectiveness analysis of whole-genome sequencing during an outbreak of carbapenem-resistant Acinetobacter baumannii. Antimicrobial Stewardship and Healthcare Epidemiology, 1 (1) e62, e62. doi: 10.1017/ash.2021.233

Isler, Burcu, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2020). An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa. The Journal of Antimicrobial Chemotherapy, 76 (3), 550-560. doi: 10.1093/jac/dkaa511

Gordon, Louisa G., Elliott, Thomas M., Forde, Brian, Mitchell, Brett, Russo, Philip L., Paterson, David L. and Harris, Patrick N. A. (2020). Budget impact analysis of routinely using whole-genomic sequencing of six multidrug-resistant bacterial pathogens in Queensland, Australia. BMJ Open, 11 (2) e041968, e041968. doi: 10.1136/bmjopen-2020-041968

van Duin, David and Paterson, David L. (2020). Multidrug-Resistant Bacteria in the Community: An Update. Infectious Disease Clinics of North America, 34 (4), 709-722. doi: 10.1016/j.idc.2020.08.002

De Oliveira, David M. P., Bohlmann, Lisa, Conroy, Trent, Jen, Freda E.-C., Everest-Dass, Arun, Hansford, Karl A., Bolisetti, Raghu, El-Deeb, Ibrahim M., Forde, Brian M., Phan, Minh-Duy, Lacey, Jake A., Tan, Aimee, Rivera-Hernandez, Tania, Brouwer, Stephan, Keller, Nadia, Kidd, Timothy J., Cork, Amanda J., Bauer, Michelle J., Cook, Gregory M., Davies, Mark R., Beatson, Scott A., Paterson, David L., McEwan, Alastair G., Li, Jian, Schembri, Mark A., Blaskovich, Mark A. T., Jennings, Michael P., McDevitt, Christopher A., von Itzstein, Mark and Walker, Mark J. (2020). Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis. Science Translational Medicine, 12 (570) abb3791, eabb3791. doi: 10.1126/scitranslmed.abb3791

Isler, Burcu, Kidd, Timothy J., Stewart, Adam G., Harris, Patrick and Paterson, David L. (2020). Achromobacter infections and treatment options. Antimicrobial Agents and Chemotherapy, 64 (11) e01025, 1-16. doi: 10.1128/aac.01025-20

Isler, Burcu, Ezure, Yukiko, García-Fogeda Romero, Jose Luis, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2020). Is ceftazidime/avibactam an option for serious infections due to ESBL and AmpC producing Enterobacterales?: a systematic review and meta-analysis. Antimicrobial Agents and Chemotherapy, 65 (1) e01052-20. doi: 10.1128/AAC.01052-20

McNamara, John F., Harris, Patrick N. A., Chatfield, Mark D. and Paterson, David L. (2020). Reply to Rezahosseini and Nielsen. Clinical Infectious Diseases, 72 (11), e916-e916. doi: 10.1093/cid/ciaa1449

Burnard, Delaney, Gore, Letitia, Henderson, Andrew, Ranasinghe, Ama, Bergh, Haakon, Cottrell, Kyra, Sarovich, Derek S., Price, Erin P., Paterson, David L. and Harris, Patrick N. A. (2020). Comparative genomics and antimicrobial resistance profiling of Elizabethkingia isolates reveals nosocomial transmission and in vitro susceptibility to fluoroquinolones, tetracyclines and trimethoprim-sulfamethoxazole. Journal of Clinical Microbiology, 58 (9) e00730-20. doi: 10.1128/jcm.00730-20

Hancock, Steven J., Phan, Minh-Duy, Luo, Zhenyao, Lo, Alvin W., Peters, Kate M., Nhu, Nguyen Thi Khanh, Forde, Brian M., Whitfield, Jason, Yang, Ji, Strugnell, Richard A., Paterson, David L., Walsh, Timothy R., Kobe, Bostjan, Beatson, Scott A. and Schembri, Mark A. (2020). Comprehensive analysis of IncC plasmid conjugation identifies a crucial role for the transcriptional regulator AcaB. Nature Microbiology, 5 (11), 1340-1348. doi: 10.1038/s41564-020-0775-0

McNamara, John F., Harris, Patrick N. A., Chatfield, Mark D. and Paterson, David L. (2020). Acute myocardial infarction and community-acquired Staphylococcus aureus bloodstream infection: an observational cohort study. Clinical Infectious Diseases, 73 (9), e2647-e2655. doi: 10.1093/cid/ciaa1197

Forde, Brian M., Henderson, Andrew, Playford, Elliott G., Looke, David, Henderson, Belinda C., Watson, Catherine, Steen, Jason A., Sidjabat, Hanna E., Laurie, Gordon, Muttaiyah, Sharmini, Nimmo, Graeme R., Lampe, Guy, Smith, Helen, Jennison, Amy V., McCall, Brad, Carroll, Heidi, Cooper, Matthew A., Paterson, David L. and Beatson, Scott A. (2020). Fatal respiratory diphtheria caused by ß-lactam–resistant corynebacterium diphtheriae. Clinical Infectious Diseases, 73 (11), e4531-e4538. doi: 10.1093/cid/ciaa1147

Roberts, Matthew J., Macdonald, Alastair, Ranasinghe, Sachinka, Bennett, Harrison, Teloken, Patrick E., Harris, Patrick, Paterson, David, Coughlin, Geoff, Dunglison, Nigel, Esler, Rachel, Gardiner, Robert A., Elliott, Thomas, Gordon, Louisa and Yaxley, John (2020). Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution. Prostate Cancer and Prostatic Diseases, 24 (1), 169-176. doi: 10.1038/s41391-020-0263-x

Abdul Rahim, Nusaibah, Cheah, Soon-Ee, Johnson, Matthew D., Zhu, Yan, Yu, Heidi H., Sidjabat, Hanna E., Butler, Mark S., Cooper, Matthew A., Fu, Jing, Paterson, David L., Nation, Roger L., Boyce, John D., Bergen, Phillip J., Velkov, Tony and Li, Jian (2020). Transcriptomic responses of a New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae isolate to the combination of polymyxin B and chloramphenicol. International Journal of Antimicrobial Agents, 56 (2) 106061, 106061. doi: 10.1016/j.ijantimicag.2020.106061

Zeitlinger, Markus, Koch, Birgit C. P., Bruggemann, Roger, De Cock, Pieter, Felton, Timothy, Hites, Maya, Le, Jennifer, Luque, Sonia, MacGowan, Alasdair P., Marriott, Deborah J. E., Muller, Anouk E., Nadrah, Kristina, Paterson, David L., Standing, Joseph F., Telles, João P., Wölfl-Duchek, Michael, Thy, Michael and Roberts, Jason A. (2020). Pharmacokinetics/pharmacodynamics of antiviral agents used to treat SARS-CoV-2 and their potential interaction with drugs and other supportive measures: a comprehensive review by the PK/PD of anti-infectives study group of the European Society of Antimicrobial Agents. Clinical Pharmacokinetics, 59 (10), 1195-1216. doi: 10.1007/s40262-020-00924-9

Stewart, Adam G., Harris, Patrick N. A., Chatfield, Mark, Evans, Scott R., van Duin, David and Paterson, David L. (2020). Modern clinician-initiated clinical trials to determine optimal therapy for multi-drug resistant Gram-negative infections. Clinical Infectious Diseases, 71 (2), 433-439. doi: 10.1093/cid/ciz1132

Denholm, Justin T., Davis, Joshua, Paterson, David, Roberts, Jason, Morpeth, Susan, Snelling, Thomas, Zentner, Dominica, Rees, Megan, O'Sullivan, Matthew, Price, David, Bowen, Asha, Tong, Steven Y. C., Davis, Joshua, Denholm, Justin, Tong, Steven, ASCOT Investigator Group, Rees, Megan, Paterson, David, Price, David, Morpeth, Susan, O'Sullivan, Matthew, Roberts, Jason, Snelling, Thomas, Anderson, Sue, McQuilton, Zoe, Venkatesh, Bala, Hammond, Naomi, Jha, Vivekanend, Burston, Victoria John ... Slow, Sandy (2020). The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial. Trials, 21 (1) 646. doi: 10.1186/s13063-020-04576-9

De Oliveira, David M. P., Forde, Brian M., Kidd, Timothy J., Harris, Patrick N. A., Schembri, Mark A., Beatson, Scott A., Paterson, David L. and Walker, Mark J. (2020). Antimicrobial resistance in ESKAPE pathogens. Clinical Microbiology Reviews, 33 (3) e00181-19, e00181-19. doi: 10.1128/cmr.00181-19

van Duin, David, Arias, Cesar A., Komarow, Lauren, Chen, Liang, Hanson, Blake M., Weston, Gregory, Cober, Eric, Garner, Omai B., Jacob, Jesse T., Satlin, Michael J., Fries, Bettina C., Garcia-Diaz, Julia, Doi, Yohei, Dhar, Sorabh, Kaye, Keith S., Earley, Michelle, Hujer, Andrea M., Hujer, Kristine M., Domitrovic, T. Nicholas, Shropshire, William C., An Dinh, , Manca, Claudia, Luterbach, Courtney L., Wang, Minggui, Paterson, David L., Banerjee, Ritu, Patel, Robin, Evans, Scott, Hill, Carol ... Bonomo, Robert A. (2020). Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study. Lancet Infectious Diseases, 20 (6), 731-741. doi: 10.1016/S1473-3099(19)30755-8

Stewart, Adam G., Harris, Patrick N. A., Henderson, Andrew, Schembri, Mark A. and Paterson, David L. (2020). Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections. Journal of Antimicrobial Chemotherapy, 75 (9), 2384-2393. doi: 10.1093/jac/dkaa183

Chapman, Paul, Forde, Brian M., Roberts, Leah W., Bergh, Haakon, Vesey, Debra, Jennison, Amy V., Moss, Susan, Paterson, David L., Beatson, Scott A. and Harris, Patrick N. A. (2020). Genomic investigation reveals contaminated detergent as the source of an Extended-Spectrum-β-Lactamase-producing Klebsiella michiganensis outbreak in a neonatal unit. Journal of Clinical Microbiology, 58 (5) e01980. doi: 10.1128/jcm.01980-19

Manning, Laurens, Metcalf, Sarah, Clark, Benjamin, Robinson, James Owen, Huggan, Paul, Luey, Chris, McBride, Stephen, Aboltins, Craig, Nelson, Renjy, Campbell, David, Solomon, Lucian Bogdan, Schneider, Kellie, Loewenthal, Mark, Yates, Piers, Athan, Eugene, Cooper, Darcie, Rad, Babak, Allworth, Tony, Reid, Alistair, Read, Kerry, Leung, Peter, Sud, Archana, Nagendra, Vana, Chean, Roy, Lemoh, Chris, Mutalima, Nora, Grimwade, Kate, Sehu, Marjorie, Torda, Adrienne ... Davis, Josh (2020). Clinical characteristics, etiology, and initial management strategy of newly diagnosed periprosthetic joint infection: a multicenter, prospective observational cohort study of 783 patients. Open Forum Infectious Diseases, 7 (5) ofaa068, 1-10. doi: 10.1093/ofid/ofaa068

Paterson, David L., Isler, Burcu and Stewart, Adam (2020). New treatment options for multiresistant gram negatives. Current Opinion in Infectious Diseases, 33 (2), 214-223. doi: 10.1097/QCO.0000000000000627

Butler, Mark S. and Paterson, David L. (2020). Antibiotics in the clinical pipeline in October 2019. The Journal of Antibiotics, 73 (6), 329-364. doi: 10.1038/s41429-020-0291-8

Foster, Andrew L., Moriarty, T. Fintan, Trampuz, Andrej, Jaiprakash, Anjali, Burch, Marc A., Crawford, Ross, Paterson, David L., Metsemakers, Willem-Jan, Schuetz, Michael and Richards, R. Geoff (2020). Fracture-related infection: current methods for prevention and treatment. Expert Review of Anti-Infective Therapy, 18 (4), 1-15. doi: 10.1080/14787210.2020.1729740

Tong, Steven Y. C., Lye, David C., Yahav, Dafna, Sud, Archana, Robinson, J. Owen, Nelson, Jane, Archuleta, Sophia, Roberts, Matthew A., Cass, Alan, Paterson, David L., Foo, Hong, Paul, Mical, Guy, Stephen D., Tramontana, Adrian R., Walls, Genevieve B., McBride, Stephen, Bak, Narin, Ghosh, Niladri, Rogers, Benjamin A., Ralph, Anna P., Davies, Jane, Ferguson, Patricia E., Dotel, Ravindra, McKew, Genevieve L., Gray, Timothy J., Holmes, Natasha E., Smith, Simon, Warner, Morgyn S., Kalimuddin, Shirin ... Davis, Joshua S. (2020). Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial. JAMA - Journal of the American Medical Association, 323 (6), 527-537. doi: 10.1001/jama.2020.0103

Paterson, David L., Henderson, Andrew and Harris, Patrick N. A. (2020). Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia. Current Opinion in Infectious Diseases, 33 (1), 78-85. doi: 10.1097/QCO.0000000000000623

McNamara, J. F., Harris, P. N. A., Chatfield, M. D., Lorenc, P. and Paterson, D. L. (2020). Measuring patient-centred long-term outcome following a bloodstream infection: a pilot study. Clinical Microbiology and Infection, 26 (2), 257.e1-257.e4. doi: 10.1016/j.cmi.2019.10.011

Babich, Tanya, Naucler, Pontus, Valik, John Karlsson, Giske, Christian G., Benito, Natividad, Cardona, Ruben, Rivera, Alba, Pulcini, Celine, Fattah, Manal Abdel, Haquin, Justine, MacGowan, Alasdair, Grier, Sally, Chazan, Bibiana, Yanovskay, Anna, Ami, Ronen Ben, Landes, Michal, Nesher, Lior, Zaidman-Shimshovitz, Adi, McCarthy, Kate, Paterson, David L., Tacconelli, Evelina, Buhl, Michael, Mauer, Susanna, Rodriguez-Bano, Jesus, Morales, Isabel, Oliver, Antonio, de Gopegui, Enrique Ruiz, Cano, Angela, Machuca, Isabel ... Yahav, Dafna (2020). Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study. International Journal of Antimicrobial Agents, 55 (2) 105847, 105847. doi: 10.1016/j.ijantimicag.2019.11.004

McNamara, John F., Avent, Minyon, Stewart, Adam, Kwan, Christopher and Paterson, David L. (2020). Evaluation of quick sequential organ failure assessment and systemic inflammatory response syndrome in patients with gram negative bloodstream infection. Infection, Disease and Health, 25 (3), 151-157. doi: 10.1016/j.idh.2020.01.003

Roberts, Leah W., Harris, Patrick N. A., Forde, Brian M., Ben Zakour, Nouri L., Catchpoole, Elizabeth, Stanton-Cook, Mitchell, Phan, Minh-Duy, Sidjabat, Hanna E., Bergh, Haakon, Heney, Claire, Gawthorne, Jayde A., Lipman, Jeffrey, Allworth, Anthony, Chan, Kok-Gan, Chong, Teik Min, Yin, Wai-Fong, Schembri, Mark A., Paterson, David L. and Beatson, Scott A. (2020). Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei. Nature Communications, 11 (1) 466, 466. doi: 10.1038/s41467-019-14139-5

Yadav, Rajbharan, Bergen, Phillip J., Rogers, Kate E., Kirkpatrick, Carl M. J., Wallis, Steven C., Huang, Yuling, Bulitta, Jürgen B., Paterson, David L., Lipman, Jeffrey, Nation, Roger L., Roberts, Jason A. and Landersdorfer, Cornelia B. (2020). Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients. Antimicrobial Agents and Chemotherapy, 64 (1) e01679-19. doi: 10.1128/aac.01679-19

Lee, Xing J., Elliott, Thomas M., Harris, Patrick N. A., Douglas, Joel, Henderson, Belinda, Watson, Catherine, Paterson, David L., Schofield, Deborah S., Graves, Nicholas and Gordon, Louisa G. (2020). Clinical and Economic Outcomes of Genome Sequencing Availability on Containing a Hospital Outbreak of Resistant Escherichia coli in Australia. Value in Health, 23 (8), 994-1002. doi: 10.1016/j.jval.2020.03.006

Roberts, Leah W., Catchpoole, Elizabeth, Jennison, Amy V., Bergh, Haakon, Hume, Anna, Heney, Claire, George, Narelle, Paterson, David L., Schembri, Mark A., Beatson, Scott A. and Harris, Patrick N. A. (2019). Genomic analysis of carbapenemase-producing Enterobacteriaceae in Queensland reveals widespread transmission of blaIMP-4 on an IncHI2 plasmid. Microbial Genomics, 6 (1) 000321. doi: 10.1099/mgen.0.000321

Peel, Trisha, Astbury, Sarah, Cheng, Allen C., Paterson, David, Buising, Kirsty, Spelman, Tim, Tran-Duy, An and de Steiger, Richard S. (2019). Multicentre randomised double-blind placebo controlled trial of combination vancomycin and cefazolin surgical antibiotic prophylaxis: the Australian surgical antibiotic prophylaxis (ASAP) trial. BMJ Open, 9 (11) 033718, e033718. doi: 10.1136/bmjopen-2019-033718

Machuca, Isabel, Gutiérrez-Gutiérrez, Belén, Rivera-Espinar, Francisco, Cano, Angela, Gracia-Ahufinger, I., Guzman-Puche, J., Marfil-Pérez, Eduardo, Pérez-Nadales, E., Castón, Juan José, Bonomo, Robert A., Carmeli, Yehuda, Paterson, D., Pascual, Álvaro, Martínez-Martínez, Luís, Rodríguez-Baño, Jesús and Torre-Cisneros, Julián (2019). External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteraemia cohort: the prognostic significance of colistin resistance. International Journal of Antimicrobial Agents, 54 (4), 442-448. doi: 10.1016/j.ijantimicag.2019.07.017

Marimuthu, Kalisvar, Ng, Oon Tek, Cherng, Benjamin Pei Zhi, Fong, Raymond Kok Choon, Pada, Surinder Kaur, De, Partha Pratim, Ooi, Say Tat, Smitasin, Nares, Thoon, Koh Cheng, Krishnan, Prabha Unny, Ang, Michelle Lay Teng, Chan, Douglas Su Gin, Kwa, Andrea Lay Hoon, Deepak, Rama Narayana, Chan, Yu Kit, Chan, Yvonne Fu Zi, Huan, Xiaowei, Linn, Kyaw Zaw, Tee, Nancy Wen Sim, Tan, Thean Yen, Koh, Tse Hsien, Lin, Raymond Tzer Pin, Hsu, Li Yang, Sengupta, Sharmila, Paterson, David L., Perencevich, Eli, Harbarth, Stephan, Teo, Jeanette, Venkatachalam, Indumathi ... Cheng, Thoon Koh (2019). Antecedent carbapenem exposure as a risk factor for non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae and carbapenemase-producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy, 63 (10) e00845-19. doi: 10.1128/AAC.00845-19

Henderson, A., Harris, P., Hartel, G., Paterson, D., Turnidge, J., Davis, J. S. and Tong, S. Y. C. (2019). Benzylpenicillin versus flucloxacillin for penicillin susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study. International Journal of Antimicrobial Agents, 54 (4), 491-495. doi: 10.1016/j.ijantimicag.2019.05.020

Huber, Charlotte A, Pflüger, Valentin, Reed, Sarah, Cottrell, Kyra, Sidjabat, Hanna E, Ranasinghe, Ama, Zowawi, Hosam, Harris, Patrick and Paterson, David L (2019). Bacterial identification using an Absciex 5800 TOF/TOF MALDI research instrument and an external database. Journal of Microbiological Methods, 164 105685, 105685. doi: 10.1016/j.mimet.2019.105685

Williamson, Deborah A, Howden, Benjamin P and Paterson, David L (2019). The risk of resistance: what are the major antimicrobial resistance threats facing Australia?. Medical Journal of Australia, 211 (3), 103-105.e1. doi: 10.5694/mja2.50249

White, Nicole M., Barnett, Adrian G., Hall, Lisa, Mitchell, Brett G., Farrington, Alison, Halton, Kate, Paterson, David L., Riley, Thomas V., Gardner, Anne, Page, Katie, Gericke, Christian A. and Graves, Nicholas (2019). Cost-effectiveness of an environmental cleaning bundle for reducing healthcare associated infections. Clinical Infectious Diseases, 70 (12), 2461-2468. doi: 10.1093/cid/ciz717

Bordin, Amanda, Trembizki, Ella, Windsor, Madeline, Wee, Rachel, Tan, Lit Yeen, Buckley, Cameron, Syrmis, Melanie, Bergh, Haakon, Cottrell, Kyra, Zowawi, Hosam M., Sidjabat, Hanna E, Harris, Patrick N. A., Nimmo, Graeme R., Paterson, David L. and Whiley, David M. (2019). Evaluation of the SpeeDx Carba (beta) multiplex real-time PCR assay for detection of NDM, KPC, OXA-48-like, IMP-4-like and VIM carbapenemase genes. BMC Infectious Diseases, 19 (1) 571, 571. doi: 10.1186/s12879-019-4176-z

Burkett, Ellen, Carpenter, Christopher R., Arendts, Glenn, Hullick, Carolyn, Paterson, David L. and Caterino, Jeffrey M. (2019). Diagnosis of urinary tract infection in older persons in the emergency department: to pee or not to pee, that is the question. Emergency Medicine Australasia, 31 (5) 1742-6723.13376, 856-862. doi: 10.1111/1742-6723.13376

Evans, Scott R., Follmann, Dean, Liu, Ying, Holland, Thomas, Doernberg, Sarah B., Rouphael, Nadine, Hamasaki, Toshimitsu, Jiang, Yunyun, Lok, Judith J., Tran, Thuy Tien T., Harris, Anthony D., Fowler, Vance G., Boucher, Helen, Kreiswirth, Barry N., Bonomo, Robert A., Van Duin, David, Paterson, David L. and Chambers, Henry (2019). Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS). Clinical Infectious Diseases, 68 (11), 1961-1967. doi: 10.1093/cid/ciy912

Lin, Yu-Wei, Rahim, Nusaibah Abdul, Zhao, Jinxin, Han, Mei-Ling, Yu, Heidi H., Wickremasinghe, Hasini, Chen, Ke, Wang, Jiping, Paterson, David L., Zhu, Yan, Rao, Gauri G., Zhou, Qi Tony, Forrest, Alan, Velkov, Tony and Li, Jian (2019). Novel polymyxin combination with the antiretroviral xidovudine exerts synergistic killing against NDM-producing multidrug-resistant Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy, 63 (4) e02176-18. doi: 10.1128/AAC.02176-18

Mitchell, Brett G., Hall, Lisa, White, Nicole, Barnett, Adrian G., Halton, Kate, Paterson, David L., Riley, Thomas V., Gardner, Anne, Page, Katie, Farrington, Alison, Gericke, Christian A. and Graves, Nicholas (2019). An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised trial. The Lancet Infectious Diseases, 19 (4), 410-418. doi: 10.1016/S1473-3099(18)30714-X

Lipman, Jeffrey, Brett, Stephen J., De Waele, Jan J., Cotta, Menino O., Davis, Joshua S., Finfer, Simon, Glass, Parisa, Knowles, Serena, McGuinness, Shay, Myburgh, John, Paterson, David L., Peake, Sandra, Rajbhandari, Dorrilyn, Rhodes, Andrew, Roberts, Jason A., Shirwadkar, Charudatt, Starr, Therese, Taylor, Colman, Billot, Laurent and Dulhunty, Joel M. (2019). A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III. Critical Care and Resuscitation, 21 (1), 63-68. doi: 10.1016/s1441-2772(23)00582-3

Cameron, Jessica K., Hall, Lisa, Tong, Steven Y. C., Paterson, David L. and Halton, Kate (2019). Incidence of community onset MRSA in Australia: least reported where it is most prevalent. Antimicrobial Resistance and Infection Control, 8 (1) 33, 33. doi: 10.1186/s13756-019-0485-7

Harris, Patrick N. A., Tambyah, Paul and Paterson, David L. (2019). Antibiotics for ceftriaxone resistant gram-negative bacterial bloodstream infections-reply. The Journal of the American Medical Association, 321 (6), 613-614. doi: 10.1001/jama.2018.19353

Professor David Paterson

Publications

Book Chapters

Journal Articles